If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> ARCHIVE<br /> Volume 109 Number 1 JANuArY 2014<br /> www.amjgastro.com<br /> official publication of the american college of gastroenterology<br /> leading articles of the month<br /> Clinical and Systematic Reviews<br /> 23 The Role of Thiopurines in Reducing the Need for Surgical<br /> Resection in Crohn’s Disease: A Systematic Review<br /> and Meta-Analysis CME<br /> S. Chatu, V. Subramanian, S. Saxena and R.C.G. Pollok<br /> Esophagus<br /> 52 Objective Manometric Criteria for the Rumination Syndrome<br /> B.F. Kessing, A.J. Bredenoord and A.J.P.M. Smout<br /> Stomach<br /> 60 Effect of Helicobacter pylori Eradication on Metachronous<br /> Recurrence After Endoscopic Resection of Gastric Neoplasm<br /> S.E. Bae, H.-Y. Jung, J. Kang, Y.S. Park, S. Baek, J.-H. Jung, J.Y. Choi,<br /> M.-Y. Kim, J.Y. Ahn, K.-S. Choi, D.H. Kim, J.H. Lee, K.D. Cho<a title="AJG_Vol.110.No.1 page 1" href="http://viewer.zmags.com/publication/46f8a1a9?page=1"> ARCHIVE Volume 109 Number 1 JANuArY 2014 www.amj</a> <a title="AJG_Vol.110.No.1 page 2" href="http://viewer.zmags.com/publication/46f8a1a9?page=2"> VOLUME 110 NUMBER 1 JANUARY 2015 www.amjgastro.</a> <a title="AJG_Vol.110.No.1 page 3" href="http://viewer.zmags.com/publication/46f8a1a9?page=3"> * *by patients in clinical trials† </a> <a title="AJG_Vol.110.No.1 page 4" href="http://viewer.zmags.com/publication/46f8a1a9?page=4"> Split-dose Prepopik demonstrated‡: EFFE</a> <a title="AJG_Vol.110.No.1 page 5" href="http://viewer.zmags.com/publication/46f8a1a9?page=5"> The following is a brief summary only; see full P</a> <a title="AJG_Vol.110.No.1 page 6" href="http://viewer.zmags.com/publication/46f8a1a9?page=6"> CATCH HER PBC BEFORE PBC CATCHES HER </a> <a title="AJG_Vol.110.No.1 page 7" href="http://viewer.zmags.com/publication/46f8a1a9?page=7"> www.amjgastro.com The American Journa</a> <a title="AJG_Vol.110.No.1 page 8" href="http://viewer.zmags.com/publication/46f8a1a9?page=8"> For the treatment of HCV in GT 1 patients </a> <a title="AJG_Vol.110.No.1 page 9" href="http://viewer.zmags.com/publication/46f8a1a9?page=9"> HARVONI is a once-daily single-tablet regimen for</a> <a title="AJG_Vol.110.No.1 page 10" href="http://viewer.zmags.com/publication/46f8a1a9?page=10"> NOW APPROVED ONE IS HERE IMPORTANT SAFETY</a> <a title="AJG_Vol.110.No.1 page 11" href="http://viewer.zmags.com/publication/46f8a1a9?page=11"> HARVONI® (ledipasvir 90 mg and sofosbuvir 400 mg)</a> <a title="AJG_Vol.110.No.1 page 12" href="http://viewer.zmags.com/publication/46f8a1a9?page=12"> Brief Summary (cont.) Consider alternative HCV</a> <a title="AJG_Vol.110.No.1 page 13" href="http://viewer.zmags.com/publication/46f8a1a9?page=13"> For patients with</a> <a title="AJG_Vol.110.No.1 page 14" href="http://viewer.zmags.com/publication/46f8a1a9?page=14"> To request samples, call 1-800-828-2845 or visit </a> <a title="AJG_Vol.110.No.1 page 15" href="http://viewer.zmags.com/publication/46f8a1a9?page=15"> BRIEF SUMMARY: Consult the Full Prescribing Infor</a> <a title="AJG_Vol.110.No.1 page 16" href="http://viewer.zmags.com/publication/46f8a1a9?page=16"> not always possible to reliably estimate their fr</a> <a title="AJG_Vol.110.No.1 page 17" href="http://viewer.zmags.com/publication/46f8a1a9?page=17"> OFFICIAL PUBLICATION OF THE AMERICAN CO</a> <a title="AJG_Vol.110.No.1 page 18" href="http://viewer.zmags.com/publication/46f8a1a9?page=18"> Looking for an easy way to diagnose SIBO? %</a> <a title="AJG_Vol.110.No.1 page 19" href="http://viewer.zmags.com/publication/46f8a1a9?page=19"> The American College of Gastroenterology Explore</a> <a title="AJG_Vol.110.No.1 page 20" href="http://viewer.zmags.com/publication/46f8a1a9?page=20"> THE MORE EDUCATED YOU ARE, THE MORE LIKELY YOU AR</a> <a title="AJG_Vol.110.No.1 page 21" href="http://viewer.zmags.com/publication/46f8a1a9?page=21"> </a> <a title="AJG_Vol.110.No.1 page 22" href="http://viewer.zmags.com/publication/46f8a1a9?page=22"> A NEW FACE IN HCV abbviehcv.com </a> <a title="AJG_Vol.110.No.1 page 23" href="http://viewer.zmags.com/publication/46f8a1a9?page=23"> Whether it's running to a sales call, or running </a> <a title="AJG_Vol.110.No.1 page 24" href="http://viewer.zmags.com/publication/46f8a1a9?page=24"> Many patients allow their disease to control thei</a> <a title="AJG_Vol.110.No.1 page 25" href="http://viewer.zmags.com/publication/46f8a1a9?page=25"> Ournationally ranked Gastroenterology and GI Surg</a> <a title="AJG_Vol.110.No.1 page 26" href="http://viewer.zmags.com/publication/46f8a1a9?page=26"> †Over a 6-month period; P<0.0001 vs placebo. Ind</a> <a title="AJG_Vol.110.No.1 page 27" href="http://viewer.zmags.com/publication/46f8a1a9?page=27"> The following is a brief summary only. See</a> <a title="AJG_Vol.110.No.1 page 28" href="http://viewer.zmags.com/publication/46f8a1a9?page=28"> Brief Summary UCERIS (budesonide) 2 mg rectal foa</a> <a title="AJG_Vol.110.No.1 page 29" href="http://viewer.zmags.com/publication/46f8a1a9?page=29"> FOR THE INDUCTION OF REMIS</a> <a title="AJG_Vol.110.No.1 page 30" href="http://viewer.zmags.com/publication/46f8a1a9?page=30"> (Top) Submucosal blue structures suggestive of sm</a> <a title="AJG_Vol.110.No.1 page 31" href="http://viewer.zmags.com/publication/46f8a1a9?page=31"> CONTENTS </a> <a title="AJG_Vol.110.No.1 page 32" href="http://viewer.zmags.com/publication/46f8a1a9?page=32"> www.amjgastro.com </a> <a title="AJG_Vol.110.No.1 page 33" href="http://viewer.zmags.com/publication/46f8a1a9?page=33"> Urgent Request for Manuscripts Address</a> <a title="AJG_Vol.110.No.1 page 34" href="http://viewer.zmags.com/publication/46f8a1a9?page=34"> BRIEF SUMMARY UCERIS (budesonide) extended releas</a> <a title="AJG_Vol.110.No.1 page 35" href="http://viewer.zmags.com/publication/46f8a1a9?page=35"> InActive,MildtoModerateUlcerativeColitis(UC) POWE</a> <a title="AJG_Vol.110.No.1 page 36" href="http://viewer.zmags.com/publication/46f8a1a9?page=36"> nature publishing group </a> <a title="AJG_Vol.110.No.1 page 37" href="http://viewer.zmags.com/publication/46f8a1a9?page=37"> 2 THE RED SECTION </a> <a title="AJG_Vol.110.No.1 page 38" href="http://viewer.zmags.com/publication/46f8a1a9?page=38"> THE RED SECTION 3 What's Hot in the RED J</a> <a title="AJG_Vol.110.No.1 page 39" href="http://viewer.zmags.com/publication/46f8a1a9?page=39"> 4 THE RED SECTION </a> <a title="AJG_Vol.110.No.1 page 40" href="http://viewer.zmags.com/publication/46f8a1a9?page=40"> “grass roots” nature of the College. He Cha</a> <a title="AJG_Vol.110.No.1 page 41" href="http://viewer.zmags.com/publication/46f8a1a9?page=41"> 6 THE RED SECTION </a> <a title="AJG_Vol.110.No.1 page 42" href="http://viewer.zmags.com/publication/46f8a1a9?page=42"> THE RED SECTION 7 ACG PRESIDENTIAL ADDRES</a> <a title="AJG_Vol.110.No.1 page 43" href="http://viewer.zmags.com/publication/46f8a1a9?page=43"> 8 THE RED SECTION ACG PRESIDENTIAL ADDRES</a> <a title="AJG_Vol.110.No.1 page 44" href="http://viewer.zmags.com/publication/46f8a1a9?page=44"> THE RED SECTION 9 ACG PRESIDENTIAL ADDRES</a> <a title="AJG_Vol.110.No.1 page 45" href="http://viewer.zmags.com/publication/46f8a1a9?page=45"> 10 THE RED SECTION </a> <a title="AJG_Vol.110.No.1 page 46" href="http://viewer.zmags.com/publication/46f8a1a9?page=46"> THE RED SECTION 11 Patients in the </a> <a title="AJG_Vol.110.No.1 page 47" href="http://viewer.zmags.com/publication/46f8a1a9?page=47"> 12 THE RED SECTION corresponding criteri</a> <a title="AJG_Vol.110.No.1 page 48" href="http://viewer.zmags.com/publication/46f8a1a9?page=48"> Table 1. Baseline demographic and clinical charac</a> <a title="AJG_Vol.110.No.1 page 49" href="http://viewer.zmags.com/publication/46f8a1a9?page=49"> 14 THE RED SECTION Table 3. Factors associ</a> <a title="AJG_Vol.110.No.1 page 50" href="http://viewer.zmags.com/publication/46f8a1a9?page=50"> nature publishing group </a> <a title="AJG_Vol.110.No.1 page 51" href="http://viewer.zmags.com/publication/46f8a1a9?page=51"> 16 THE RED SECTION </a> <a title="AJG_Vol.110.No.1 page 52" href="http://viewer.zmags.com/publication/46f8a1a9?page=52"> nature publishing group </a> <a title="AJG_Vol.110.No.1 page 53" href="http://viewer.zmags.com/publication/46f8a1a9?page=53"> 18 PRACTICE GUIDELINES </a> <a title="AJG_Vol.110.No.1 page 54" href="http://viewer.zmags.com/publication/46f8a1a9?page=54"> ACG Clinical Guideline 19 Table 1. Recom</a> <a title="AJG_Vol.110.No.1 page 55" href="http://viewer.zmags.com/publication/46f8a1a9?page=55"> 20 Brandt et al. Table 1. Continued Co</a> <a title="AJG_Vol.110.No.1 page 56" href="http://viewer.zmags.com/publication/46f8a1a9?page=56"> stimulation. What triggers the episode of CI, how</a> <a title="AJG_Vol.110.No.1 page 57" href="http://viewer.zmags.com/publication/46f8a1a9?page=57"> 22 Brandt et al. Table 2. Medical condit</a> <a title="AJG_Vol.110.No.1 page 58" href="http://viewer.zmags.com/publication/46f8a1a9?page=58"> with IBS and constipation, respectively, than for</a> <a title="AJG_Vol.110.No.1 page 59" href="http://viewer.zmags.com/publication/46f8a1a9?page=59"> 24 Brandt et al. Table 3. Drugs proposed</a> <a title="AJG_Vol.110.No.1 page 60" href="http://viewer.zmags.com/publication/46f8a1a9?page=60"> ACG Clinical Guideline 25 Table 3. Conti</a> <a title="AJG_Vol.110.No.1 page 61" href="http://viewer.zmags.com/publication/46f8a1a9?page=61"> 26 Brandt et al. in 1–2 weeks. With se</a> <a title="AJG_Vol.110.No.1 page 62" href="http://viewer.zmags.com/publication/46f8a1a9?page=62"> ACG Clinical Guideline 27 Table 4. Segmen</a> <a title="AJG_Vol.110.No.1 page 63" href="http://viewer.zmags.com/publication/46f8a1a9?page=63"> 28 Brandt et al. and sepsis (70%) was </a> <a title="AJG_Vol.110.No.1 page 64" href="http://viewer.zmags.com/publication/46f8a1a9?page=64"> Longstreth and Yao (9) found no evidence of chr</a> <a title="AJG_Vol.110.No.1 page 65" href="http://viewer.zmags.com/publication/46f8a1a9?page=65"> 30 Brandt et al. part of the initial s</a> <a title="AJG_Vol.110.No.1 page 66" href="http://viewer.zmags.com/publication/46f8a1a9?page=66"> ACG Clinical Guideline 31 Table 6. Class</a> <a title="AJG_Vol.110.No.1 page 67" href="http://viewer.zmags.com/publication/46f8a1a9?page=67"> 32 Brandt et al. Table 7. Predictors of</a> <a title="AJG_Vol.110.No.1 page 68" href="http://viewer.zmags.com/publication/46f8a1a9?page=68"> patients over 60 years of age and hence the signi</a> <a title="AJG_Vol.110.No.1 page 69" href="http://viewer.zmags.com/publication/46f8a1a9?page=69"> 34 Brandt et al. not recommend angiogr</a> <a title="AJG_Vol.110.No.1 page 70" href="http://viewer.zmags.com/publication/46f8a1a9?page=70"> ACG Clinical Guideline 35 Algorithm for</a> <a title="AJG_Vol.110.No.1 page 71" href="http://viewer.zmags.com/publication/46f8a1a9?page=71"> 36 Brandt et al. Table 8. Modified Brand</a> <a title="AJG_Vol.110.No.1 page 72" href="http://viewer.zmags.com/publication/46f8a1a9?page=72"> predictors in decreasing order of significance we</a> <a title="AJG_Vol.110.No.1 page 73" href="http://viewer.zmags.com/publication/46f8a1a9?page=73"> 38 Brandt et al. were based on experim</a> <a title="AJG_Vol.110.No.1 page 74" href="http://viewer.zmags.com/publication/46f8a1a9?page=74"> The optimal duration of antimicrobial therapy i</a> <a title="AJG_Vol.110.No.1 page 75" href="http://viewer.zmags.com/publication/46f8a1a9?page=75"> 40 Brandt et al. Table 10. Surgical res</a> <a title="AJG_Vol.110.No.1 page 76" href="http://viewer.zmags.com/publication/46f8a1a9?page=76"> considered as part of the risk assessment of pati</a> <a title="AJG_Vol.110.No.1 page 77" href="http://viewer.zmags.com/publication/46f8a1a9?page=77"> 42 Brandt et al. 35. Michael H, Brand</a> <a title="AJG_Vol.110.No.1 page 78" href="http://viewer.zmags.com/publication/46f8a1a9?page=78"> 94. Huguier M, Barrier A, Boelle PY et al. Isch</a> <a title="AJG_Vol.110.No.1 page 79" href="http://viewer.zmags.com/publication/46f8a1a9?page=79"> 44 Brandt et al. 154. Plonka AJ, Schen</a> <a title="AJG_Vol.110.No.1 page 80" href="http://viewer.zmags.com/publication/46f8a1a9?page=80"> nature publishing group </a> <a title="AJG_Vol.110.No.1 page 81" href="http://viewer.zmags.com/publication/46f8a1a9?page=81"> 46 QUALITY INDICATORS FOR GI ENDOSCOPIC PROCED</a> <a title="AJG_Vol.110.No.1 page 82" href="http://viewer.zmags.com/publication/46f8a1a9?page=82"> quality improvement efforts, which was the primar</a> <a title="AJG_Vol.110.No.1 page 83" href="http://viewer.zmags.com/publication/46f8a1a9?page=83"> 48 QUALITY INDICATORS FOR GI ENDOSCOPIC PROCED</a> <a title="AJG_Vol.110.No.1 page 84" href="http://viewer.zmags.com/publication/46f8a1a9?page=84"> Quality Indicators Common to All GI Endoscopic Pr</a> <a title="AJG_Vol.110.No.1 page 85" href="http://viewer.zmags.com/publication/46f8a1a9?page=85"> 50 Rizk et al. Table 3. Summary of prop</a> <a title="AJG_Vol.110.No.1 page 86" href="http://viewer.zmags.com/publication/46f8a1a9?page=86"> outweigh any possible benefit to the patient. ASG</a> <a title="AJG_Vol.110.No.1 page 87" href="http://viewer.zmags.com/publication/46f8a1a9?page=87"> 52 Rizk et al. 4. Frequency with which</a> <a title="AJG_Vol.110.No.1 page 88" href="http://viewer.zmags.com/publication/46f8a1a9?page=88"> General anesthesia is a drug-induced loss of c</a> <a title="AJG_Vol.110.No.1 page 89" href="http://viewer.zmags.com/publication/46f8a1a9?page=89"> 54 Rizk et al. 4. Are referring physi</a> <a title="AJG_Vol.110.No.1 page 90" href="http://viewer.zmags.com/publication/46f8a1a9?page=90"> Any sedation-related event including airway ma</a> <a title="AJG_Vol.110.No.1 page 91" href="http://viewer.zmags.com/publication/46f8a1a9?page=91"> 56 Rizk et al. generating systems may </a> <a title="AJG_Vol.110.No.1 page 92" href="http://viewer.zmags.com/publication/46f8a1a9?page=92"> 21. Frequency with which postprocedure and late a</a> <a title="AJG_Vol.110.No.1 page 93" href="http://viewer.zmags.com/publication/46f8a1a9?page=93"> 58 Rizk et al. recommended performance</a> <a title="AJG_Vol.110.No.1 page 94" href="http://viewer.zmags.com/publication/46f8a1a9?page=94"> at http://www.asahq.org/For-Members/Standa</a> <a title="AJG_Vol.110.No.1 page 95" href="http://viewer.zmags.com/publication/46f8a1a9?page=95"> 60 QUALITY INDICATORS FOR GI ENDOSCOPIC PROCED</a> <a title="AJG_Vol.110.No.1 page 96" href="http://viewer.zmags.com/publication/46f8a1a9?page=96"> Quality Indicators for EGD 61 Table 1. Gr</a> <a title="AJG_Vol.110.No.1 page 97" href="http://viewer.zmags.com/publication/46f8a1a9?page=97"> 62 Park et al. Table 2. Summary of propo</a> <a title="AJG_Vol.110.No.1 page 98" href="http://viewer.zmags.com/publication/46f8a1a9?page=98"> Quality Indicators for EGD 63 Table 3. I</a> <a title="AJG_Vol.110.No.1 page 99" href="http://viewer.zmags.com/publication/46f8a1a9?page=99"> 64 Park et al. day as the procedure (o</a> <a title="AJG_Vol.110.No.1 page 100" href="http://viewer.zmags.com/publication/46f8a1a9?page=100"> 7. Frequency with which a complete examination of</a> <a title="AJG_Vol.110.No.1 page 101" href="http://viewer.zmags.com/publication/46f8a1a9?page=101"> 66 Park et al. that are suspicious for</a> <a title="AJG_Vol.110.No.1 page 102" href="http://viewer.zmags.com/publication/46f8a1a9?page=102"> tion in conjunction with a second modality, such </a> <a title="AJG_Vol.110.No.1 page 103" href="http://viewer.zmags.com/publication/46f8a1a9?page=103"> 68 Park et al. 20. Frequency with whic</a> <a title="AJG_Vol.110.No.1 page 104" href="http://viewer.zmags.com/publication/46f8a1a9?page=104"> Quality Indicators for EGD 69 Table 4. S</a> <a title="AJG_Vol.110.No.1 page 105" href="http://viewer.zmags.com/publication/46f8a1a9?page=105"> 70 Park et al. Table 5. Priority qualit</a> <a title="AJG_Vol.110.No.1 page 106" href="http://viewer.zmags.com/publication/46f8a1a9?page=106"> 36. Wang KK, Sampliner RE. Practice Parameters Co</a> <a title="AJG_Vol.110.No.1 page 107" href="http://viewer.zmags.com/publication/46f8a1a9?page=107"> 72 QUALITY INDICATORS FOR GI ENDOSCOPIC PROCED</a> <a title="AJG_Vol.110.No.1 page 108" href="http://viewer.zmags.com/publication/46f8a1a9?page=108"> METHODOLOGY In 2006, the American Society for Gas</a> <a title="AJG_Vol.110.No.1 page 109" href="http://viewer.zmags.com/publication/46f8a1a9?page=109"> 74 Rex et al. if the endoscopists are </a> <a title="AJG_Vol.110.No.1 page 110" href="http://viewer.zmags.com/publication/46f8a1a9?page=110"> of sedation or insertion of the endoscope. Common</a> <a title="AJG_Vol.110.No.1 page 111" href="http://viewer.zmags.com/publication/46f8a1a9?page=111"> 76 Rex et al. 2. Frequency with which </a> <a title="AJG_Vol.110.No.1 page 112" href="http://viewer.zmags.com/publication/46f8a1a9?page=112"> blood testing during that interval is extremely l</a> <a title="AJG_Vol.110.No.1 page 113" href="http://viewer.zmags.com/publication/46f8a1a9?page=113"> 78 Rex et al. patient monitoring (38).</a> <a title="AJG_Vol.110.No.1 page 114" href="http://viewer.zmags.com/publication/46f8a1a9?page=114"> to the ileocecal valve, so that the entire cecal </a> <a title="AJG_Vol.110.No.1 page 115" href="http://viewer.zmags.com/publication/46f8a1a9?page=115"> 80 Rex et al. had another colonoscopy </a> <a title="AJG_Vol.110.No.1 page 116" href="http://viewer.zmags.com/publication/46f8a1a9?page=116"> a sessile serrated polyp/adenoma is not an adenom</a> <a title="AJG_Vol.110.No.1 page 117" href="http://viewer.zmags.com/publication/46f8a1a9?page=117"> 82 Rex et al. 11. Frequency of recomme</a> <a title="AJG_Vol.110.No.1 page 118" href="http://viewer.zmags.com/publication/46f8a1a9?page=118"> 12. Which technical adjuncts or imaging tools, if</a> <a title="AJG_Vol.110.No.1 page 119" href="http://viewer.zmags.com/publication/46f8a1a9?page=119"> 84 Rex et al. (164). For polyps >2 cm </a> <a title="AJG_Vol.110.No.1 page 120" href="http://viewer.zmags.com/publication/46f8a1a9?page=120"> Priority indicators for colonoscopy For colonosco</a> <a title="AJG_Vol.110.No.1 page 121" href="http://viewer.zmags.com/publication/46f8a1a9?page=121"> 86 Rex et al. be measured readily in a</a> <a title="AJG_Vol.110.No.1 page 122" href="http://viewer.zmags.com/publication/46f8a1a9?page=122"> REFERENCES </a> <a title="AJG_Vol.110.No.1 page 123" href="http://viewer.zmags.com/publication/46f8a1a9?page=123"> 88 Rex et al. 52. Selby JV, Friedman </a> <a title="AJG_Vol.110.No.1 page 124" href="http://viewer.zmags.com/publication/46f8a1a9?page=124"> 101. Imperiale T, Wagner D, Lin C et al. Risk of </a> <a title="AJG_Vol.110.No.1 page 125" href="http://viewer.zmags.com/publication/46f8a1a9?page=125"> 90 Rex et al. 156. Uno Y, Obara K, Zhen</a> <a title="AJG_Vol.110.No.1 page 126" href="http://viewer.zmags.com/publication/46f8a1a9?page=126"> nature publishing group </a> <a title="AJG_Vol.110.No.1 page 127" href="http://viewer.zmags.com/publication/46f8a1a9?page=127"> 92 Adler et al. Table 1. Grades of recom</a> <a title="AJG_Vol.110.No.1 page 128" href="http://viewer.zmags.com/publication/46f8a1a9?page=128"> Quality Indicators for ERCP 93 Table 2. </a> <a title="AJG_Vol.110.No.1 page 129" href="http://viewer.zmags.com/publication/46f8a1a9?page=129"> 94 Adler et al. Table 3. Appropriate in</a> <a title="AJG_Vol.110.No.1 page 130" href="http://viewer.zmags.com/publication/46f8a1a9?page=130"> Quality Indicators for ERCP 95 Table 4. </a> <a title="AJG_Vol.110.No.1 page 131" href="http://viewer.zmags.com/publication/46f8a1a9?page=131"> 96 Adler et al. after liver transplant</a> <a title="AJG_Vol.110.No.1 page 132" href="http://viewer.zmags.com/publication/46f8a1a9?page=132"> performer. A recent meta-analysis with a random-e</a> <a title="AJG_Vol.110.No.1 page 133" href="http://viewer.zmags.com/publication/46f8a1a9?page=133"> 98 Adler et al. stent placement, the e</a> <a title="AJG_Vol.110.No.1 page 134" href="http://viewer.zmags.com/publication/46f8a1a9?page=134"> 1 to 7%, excluding certain high-risk patient subs</a> <a title="AJG_Vol.110.No.1 page 135" href="http://viewer.zmags.com/publication/46f8a1a9?page=135"> 100 Adler et al. Table 5. Priority quali</a> <a title="AJG_Vol.110.No.1 page 136" href="http://viewer.zmags.com/publication/46f8a1a9?page=136"> 20. Mazaki T, Masuda H, Takayama T. Prophylactic </a> <a title="AJG_Vol.110.No.1 page 137" href="http://viewer.zmags.com/publication/46f8a1a9?page=137"> 102 QUALITY INDICATORS FOR GI ENDOSCOPIC PROCE</a> <a title="AJG_Vol.110.No.1 page 138" href="http://viewer.zmags.com/publication/46f8a1a9?page=138"> Quality Indicators for EUS 103 Table 1. G</a> <a title="AJG_Vol.110.No.1 page 139" href="http://viewer.zmags.com/publication/46f8a1a9?page=139"> 104 Wani et al. Table 2. Summary of pro</a> <a title="AJG_Vol.110.No.1 page 140" href="http://viewer.zmags.com/publication/46f8a1a9?page=140"> Table 3. Appropriate indications for EUS (6,7) St</a> <a title="AJG_Vol.110.No.1 page 141" href="http://viewer.zmags.com/publication/46f8a1a9?page=141"> 106 Wani et al. 4. Frequency with whic</a> <a title="AJG_Vol.110.No.1 page 142" href="http://viewer.zmags.com/publication/46f8a1a9?page=142"> involvement (e.g., portal vein/superior mesenteri</a> <a title="AJG_Vol.110.No.1 page 143" href="http://viewer.zmags.com/publication/46f8a1a9?page=143"> 108 Wani et al. evaluation of resected</a> <a title="AJG_Vol.110.No.1 page 144" href="http://viewer.zmags.com/publication/46f8a1a9?page=144"> EUS-FNA specific morbidity rate of 0.98% (107/10,</a> <a title="AJG_Vol.110.No.1 page 145" href="http://viewer.zmags.com/publication/46f8a1a9?page=145"> 110 Wani et al. Priority indicators fo</a> <a title="AJG_Vol.110.No.1 page 146" href="http://viewer.zmags.com/publication/46f8a1a9?page=146"> tifying poor performers and retraining them so th</a> <a title="AJG_Vol.110.No.1 page 147" href="http://viewer.zmags.com/publication/46f8a1a9?page=147"> 112 Wani et al. 34. Janssen J, Konig K</a> <a title="AJG_Vol.110.No.1 page 148" href="http://viewer.zmags.com/publication/46f8a1a9?page=148"> 83. Moller K, Papanikolaou IS, Toermer T et al. </a> <a title="AJG_Vol.110.No.1 page 149" href="http://viewer.zmags.com/publication/46f8a1a9?page=149"> 114 REVIEWS FROM THE ACG ANNUAL MEETING </a> <a title="AJG_Vol.110.No.1 page 150" href="http://viewer.zmags.com/publication/46f8a1a9?page=150"> formulated to be active in the distal ileum and r</a> <a title="AJG_Vol.110.No.1 page 151" href="http://viewer.zmags.com/publication/46f8a1a9?page=151"> 116 Bernstein study revealed the effic</a> <a title="AJG_Vol.110.No.1 page 152" href="http://viewer.zmags.com/publication/46f8a1a9?page=152"> linked to the JC virus) seen with natalizumab (wh</a> <a title="AJG_Vol.110.No.1 page 153" href="http://viewer.zmags.com/publication/46f8a1a9?page=153"> 118 Bernstein for a variety of differe</a> <a title="AJG_Vol.110.No.1 page 154" href="http://viewer.zmags.com/publication/46f8a1a9?page=154"> adverse effects. Therefore, more data for each of</a> <a title="AJG_Vol.110.No.1 page 155" href="http://viewer.zmags.com/publication/46f8a1a9?page=155"> 120 Bernstein symptoms with immunomodu</a> <a title="AJG_Vol.110.No.1 page 156" href="http://viewer.zmags.com/publication/46f8a1a9?page=156"> of respondents specifically to relieve symptoms a</a> <a title="AJG_Vol.110.No.1 page 157" href="http://viewer.zmags.com/publication/46f8a1a9?page=157"> 122 Bernstein surgery in patients with</a> <a title="AJG_Vol.110.No.1 page 158" href="http://viewer.zmags.com/publication/46f8a1a9?page=158"> diarrheal drug, 5 preferred diphenoxylate, and 5 </a> <a title="AJG_Vol.110.No.1 page 159" href="http://viewer.zmags.com/publication/46f8a1a9?page=159"> 124 Bernstein a common predictor of in</a> <a title="AJG_Vol.110.No.1 page 160" href="http://viewer.zmags.com/publication/46f8a1a9?page=160"> 30. Danese S, Fiorino G, Peyrin-Biroulet L. Biolo</a> <a title="AJG_Vol.110.No.1 page 161" href="http://viewer.zmags.com/publication/46f8a1a9?page=161"> 126 Bernstein 80. Storr M, Devlin S, Ka</a> <a title="AJG_Vol.110.No.1 page 162" href="http://viewer.zmags.com/publication/46f8a1a9?page=162"> nature publishing group </a> <a title="AJG_Vol.110.No.1 page 163" href="http://viewer.zmags.com/publication/46f8a1a9?page=163"> 128 Bharucha et al. REVIEW Table 1. Epidem</a> <a title="AJG_Vol.110.No.1 page 164" href="http://viewer.zmags.com/publication/46f8a1a9?page=164"> adults aged ≥65 years, the incidence rate of FI o</a> <a title="AJG_Vol.110.No.1 page 165" href="http://viewer.zmags.com/publication/46f8a1a9?page=165"> 130 Bharucha et al. REVIEW cumulative cost</a> <a title="AJG_Vol.110.No.1 page 166" href="http://viewer.zmags.com/publication/46f8a1a9?page=166"> gated by internet- and telephone-based daily repo</a> <a title="AJG_Vol.110.No.1 page 167" href="http://viewer.zmags.com/publication/46f8a1a9?page=167"> 132 Bharucha et al. REVIEW orders Network </a> <a title="AJG_Vol.110.No.1 page 168" href="http://viewer.zmags.com/publication/46f8a1a9?page=168"> studies suggest that even asymptomatic older null</a> <a title="AJG_Vol.110.No.1 page 169" href="http://viewer.zmags.com/publication/46f8a1a9?page=169"> 134 Bharucha et al. REVIEW SUGGESTIONS FOR</a> <a title="AJG_Vol.110.No.1 page 170" href="http://viewer.zmags.com/publication/46f8a1a9?page=170"> 30. Dunivan GC, Heymen S, Palsson OS et al. Fec</a> <a title="AJG_Vol.110.No.1 page 171" href="http://viewer.zmags.com/publication/46f8a1a9?page=171"> 136 Bharucha et al. REVIEW 83. Bannister</a> <a title="AJG_Vol.110.No.1 page 172" href="http://viewer.zmags.com/publication/46f8a1a9?page=172"> nature publishing group </a> <a title="AJG_Vol.110.No.1 page 173" href="http://viewer.zmags.com/publication/46f8a1a9?page=173"> 138 CLINICAL AND SYSTEMATIC REVIEWS </a> <a title="AJG_Vol.110.No.1 page 174" href="http://viewer.zmags.com/publication/46f8a1a9?page=174"> pads or protective garments, often supplemented b</a> <a title="AJG_Vol.110.No.1 page 175" href="http://viewer.zmags.com/publication/46f8a1a9?page=175"> 140 Whitehead et al. REVIEW taught by a he</a> <a title="AJG_Vol.110.No.1 page 176" href="http://viewer.zmags.com/publication/46f8a1a9?page=176"> tive RCTs that are not restricted to patients wit</a> <a title="AJG_Vol.110.No.1 page 177" href="http://viewer.zmags.com/publication/46f8a1a9?page=177"> 142 Whitehead et al. REVIEW Thiersch ring </a> <a title="AJG_Vol.110.No.1 page 178" href="http://viewer.zmags.com/publication/46f8a1a9?page=178"> NIH Workshop on Treatment of Fecal Incontinence </a> <a title="AJG_Vol.110.No.1 page 179" href="http://viewer.zmags.com/publication/46f8a1a9?page=179"> 144 Whitehead et al. REVIEW Box 4. Key poi</a> <a title="AJG_Vol.110.No.1 page 180" href="http://viewer.zmags.com/publication/46f8a1a9?page=180"> and overcome patient barriers to medical consulta</a> <a title="AJG_Vol.110.No.1 page 181" href="http://viewer.zmags.com/publication/46f8a1a9?page=181"> 146 Whitehead et al. REVIEW 34. Wexner SD,</a> <a title="AJG_Vol.110.No.1 page 182" href="http://viewer.zmags.com/publication/46f8a1a9?page=182"> nature publishing group </a> <a title="AJG_Vol.110.No.1 page 183" href="http://viewer.zmags.com/publication/46f8a1a9?page=183"> 148 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.110.No.1 page 184" href="http://viewer.zmags.com/publication/46f8a1a9?page=184"> Screening for BE in high-risk individuals coupl</a> <a title="AJG_Vol.110.No.1 page 185" href="http://viewer.zmags.com/publication/46f8a1a9?page=185"> 150 Sami et al. Mobile unit TNE ESOPHAG</a> <a title="AJG_Vol.110.No.1 page 186" href="http://viewer.zmags.com/publication/46f8a1a9?page=186"> Screening for BE: A Randomized Community Trial </a> <a title="AJG_Vol.110.No.1 page 187" href="http://viewer.zmags.com/publication/46f8a1a9?page=187"> 152 Sami et al. ESOPHAGUS Table 1. Baselin</a> <a title="AJG_Vol.110.No.1 page 188" href="http://viewer.zmags.com/publication/46f8a1a9?page=188"> Screening for BE: A Randomized Community Trial </a> <a title="AJG_Vol.110.No.1 page 189" href="http://viewer.zmags.com/publication/46f8a1a9?page=189"> 154 Sami et al. ESOPHAGUS Table 3. Proport</a> <a title="AJG_Vol.110.No.1 page 190" href="http://viewer.zmags.com/publication/46f8a1a9?page=190"> Screening for BE: A Randomized Community Trial </a> <a title="AJG_Vol.110.No.1 page 191" href="http://viewer.zmags.com/publication/46f8a1a9?page=191"> 156 Sami et al. ESOPHAGUS DISCUSSION We re</a> <a title="AJG_Vol.110.No.1 page 192" href="http://viewer.zmags.com/publication/46f8a1a9?page=192"> subjects with reflux symptoms and other baseline </a> <a title="AJG_Vol.110.No.1 page 193" href="http://viewer.zmags.com/publication/46f8a1a9?page=193"> 158 Sami et al. ESOPHAGUS 12. Shariff MK, </a> <a title="AJG_Vol.110.No.1 page 194" href="http://viewer.zmags.com/publication/46f8a1a9?page=194"> nature publishing group </a> <a title="AJG_Vol.110.No.1 page 195" href="http://viewer.zmags.com/publication/46f8a1a9?page=195"> 160 Sands et al. LIVER fibrosis (e.g., the</a> <a title="AJG_Vol.110.No.1 page 196" href="http://viewer.zmags.com/publication/46f8a1a9?page=196"> of the consequences of fibrosis progression (15).</a> <a title="AJG_Vol.110.No.1 page 197" href="http://viewer.zmags.com/publication/46f8a1a9?page=197"> 162 Sands et al. LIVER Table 1. Subject ba</a> <a title="AJG_Vol.110.No.1 page 198" href="http://viewer.zmags.com/publication/46f8a1a9?page=198"> Metabolic Phenotypes of CHC-Induced Liver Fibrosi</a> <a title="AJG_Vol.110.No.1 page 199" href="http://viewer.zmags.com/publication/46f8a1a9?page=199"> 164 Sands et al. 150 100 50 0 LI</a> <a title="AJG_Vol.110.No.1 page 200" href="http://viewer.zmags.com/publication/46f8a1a9?page=200"> F3/F4 (Table 2), further indicating that these ar</a> <a title="AJG_Vol.110.No.1 page 201" href="http://viewer.zmags.com/publication/46f8a1a9?page=201"> 166 Sands et al. Table 2. O-PLS model st</a> <a title="AJG_Vol.110.No.1 page 202" href="http://viewer.zmags.com/publication/46f8a1a9?page=202"> Metabolic Phenotypes of CHC-Induced Liver Fibrosi</a> <a title="AJG_Vol.110.No.1 page 203" href="http://viewer.zmags.com/publication/46f8a1a9?page=203"> 168 Sands et al. LIVER (ELF) rather than i</a> <a title="AJG_Vol.110.No.1 page 204" href="http://viewer.zmags.com/publication/46f8a1a9?page=204"> 13. Robertson DG, Frevert U. Metabolomics in drug</a> <a title="AJG_Vol.110.No.1 page 205" href="http://viewer.zmags.com/publication/46f8a1a9?page=205"> 170 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.110.No.1 page 206" href="http://viewer.zmags.com/publication/46f8a1a9?page=206"> Although there is evolving evidence that EHRs c</a> <a title="AJG_Vol.110.No.1 page 207" href="http://viewer.zmags.com/publication/46f8a1a9?page=207"> 172 Almario et al. FUNCTIONAL GI DISORDERS </a> <a title="AJG_Vol.110.No.1 page 208" href="http://viewer.zmags.com/publication/46f8a1a9?page=208"> December 2013. They were either recruited directl</a> <a title="AJG_Vol.110.No.1 page 209" href="http://viewer.zmags.com/publication/46f8a1a9?page=209"> 174 Almario et al. FUNCTIONAL GI DISORDERS </a> <a title="AJG_Vol.110.No.1 page 210" href="http://viewer.zmags.com/publication/46f8a1a9?page=210"> Computer-Generated Vs. Physician HPIs 175 </a> <a title="AJG_Vol.110.No.1 page 211" href="http://viewer.zmags.com/publication/46f8a1a9?page=211"> 176 Almario et al. FUNCTIONAL GI DISORDERS </a> <a title="AJG_Vol.110.No.1 page 212" href="http://viewer.zmags.com/publication/46f8a1a9?page=212"> during the visit might improve upon this mismatch</a> <a title="AJG_Vol.110.No.1 page 213" href="http://viewer.zmags.com/publication/46f8a1a9?page=213"> 178 Almario et al. 10. Ventres W, Kooie</a> <a title="AJG_Vol.110.No.1 page 214" href="http://viewer.zmags.com/publication/46f8a1a9?page=214"> sternum. He rarely chokes or gags on liquid or fo</a> <a title="AJG_Vol.110.No.1 page 215" href="http://viewer.zmags.com/publication/46f8a1a9?page=215"> 180 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.110.No.1 page 216" href="http://viewer.zmags.com/publication/46f8a1a9?page=216"> Table 1. The original Paris classification of earl</a> <a title="AJG_Vol.110.No.1 page 217" href="http://viewer.zmags.com/publication/46f8a1a9?page=217"> 182 van Doorn et al. The Paris classi</a> <a title="AJG_Vol.110.No.1 page 218" href="http://viewer.zmags.com/publication/46f8a1a9?page=218"> Interobserver Agreement Paris Classification </a> <a title="AJG_Vol.110.No.1 page 219" href="http://viewer.zmags.com/publication/46f8a1a9?page=219"> 184 van Doorn et al. COLON/SMALL BOWEL Tab</a> <a title="AJG_Vol.110.No.1 page 220" href="http://viewer.zmags.com/publication/46f8a1a9?page=220"> Interobserver Agreement Paris Classification </a> <a title="AJG_Vol.110.No.1 page 221" href="http://viewer.zmags.com/publication/46f8a1a9?page=221"> 186 van Doorn et al. COLON/SMALL BOWEL A</a> <a title="AJG_Vol.110.No.1 page 222" href="http://viewer.zmags.com/publication/46f8a1a9?page=222"> 3. Boenicke L, Fein M, Sailer M et al. The concu</a> <a title="AJG_Vol.110.No.1 page 223" href="http://viewer.zmags.com/publication/46f8a1a9?page=223"> 188 EDITORIAL </a> <a title="AJG_Vol.110.No.1 page 224" href="http://viewer.zmags.com/publication/46f8a1a9?page=224"> Editorial 189 Table 1. Hypothesized utili</a> <a title="AJG_Vol.110.No.1 page 225" href="http://viewer.zmags.com/publication/46f8a1a9?page=225"> 190 Gupta COLON/SMALL BOWEL also have been</a> <a title="AJG_Vol.110.No.1 page 226" href="http://viewer.zmags.com/publication/46f8a1a9?page=226"> 11. Soetikno RM, Kaltenbach T, Rouse RV et al. Pr</a> <a title="AJG_Vol.110.No.1 page 227" href="http://viewer.zmags.com/publication/46f8a1a9?page=227"> 192 LETTERS TO THE EDITOR </a> <a title="AJG_Vol.110.No.1 page 228" href="http://viewer.zmags.com/publication/46f8a1a9?page=228"> nature publishing group </a> <a title="AJG_Vol.110.No.1 page 229" href="http://viewer.zmags.com/publication/46f8a1a9?page=229"> 194 Letters to the Editor </a> <a title="AJG_Vol.110.No.1 page 230" href="http://viewer.zmags.com/publication/46f8a1a9?page=230"> nature publishing group </a> <a title="AJG_Vol.110.No.1 page 231" href="http://viewer.zmags.com/publication/46f8a1a9?page=231"> 196 Letters to the Editor </a> <a title="AJG_Vol.110.No.1 page 232" href="http://viewer.zmags.com/publication/46f8a1a9?page=232"> nature publishing group </a> <a title="AJG_Vol.110.No.1 page 233" href="http://viewer.zmags.com/publication/46f8a1a9?page=233"> 198 Letters to the Editor </a> <a title="AJG_Vol.110.No.1 page 234" href="http://viewer.zmags.com/publication/46f8a1a9?page=234"> nature publishing group </a> <a title="AJG_Vol.110.No.1 page 235" href="http://viewer.zmags.com/publication/46f8a1a9?page=235"> 200 Letters to the Editor </a> <a title="AJG_Vol.110.No.1 page 236" href="http://viewer.zmags.com/publication/46f8a1a9?page=236"> nature publishing group </a> <a title="AJG_Vol.110.No.1 page 237" href="http://viewer.zmags.com/publication/46f8a1a9?page=237"> 202 Letters to the Editor </a> <a title="AJG_Vol.110.No.1 page 238" href="http://viewer.zmags.com/publication/46f8a1a9?page=238"> nature publishing group </a> <a title="AJG_Vol.110.No.1 page 239" href="http://viewer.zmags.com/publication/46f8a1a9?page=239"> 204 ERRATA, CORRIGENDA AND RETRACTIONS </a> <a title="AJG_Vol.110.No.1 page 240" href="http://viewer.zmags.com/publication/46f8a1a9?page=240"> CLASSIFIEDS www.naturejobs.com Please get in </a> <a title="AJG_Vol.110.No.1 page 241" href="http://viewer.zmags.com/publication/46f8a1a9?page=241"> Gastroenterology Call This Top 10 “Best Places to</a> <a title="AJG_Vol.110.No.1 page 242" href="http://viewer.zmags.com/publication/46f8a1a9?page=242"> ĆĒĊėĎĈĆēĈĔđđĊČĊĔċČĆĘęėĔĊēęĊėĔđĔČĞ ACG2015 Haw</a> <a title="AJG_Vol.110.No.1 page 243" href="http://viewer.zmags.com/publication/46f8a1a9?page=243"> subject areas Stay up to date on key develop</a> <a title="AJG_Vol.110.No.1 page 244" href="http://viewer.zmags.com/publication/46f8a1a9?page=244"> </a> <a title="AJG_Vol.110.No.1 page 245" href="http://viewer.zmags.com/publication/46f8a1a9?page=245"> </a>